NSAID use increases the risk of miscarriage

December 9, 2011

Pregnant women who take NSAIDs such as naproxen (Aleve), ibuprofen (Advil), diclofenac (Volaren, Cambia), celecoxib (Celebrex), and other are two and a half times more likely to have a miscarriage. This is a finding of Canadian researchers who examined the records of 4,705 women who had a miscarriage. Surprisingly, they did not find that the risk was higher with a higher dose of NSAIDs. NSAIDs are particularly dangerous in the third trimester, when they can also cause heart problems in the fetus. Instead of NSAIDs pregnant women can try taking acetaminophen (Tylenol), which unfortunately is not a very effective pain killer. Narcotic or opioid drugs, such as codeine, Vicodin and similar drugs are not safe in pregnancy either, but can be used occasionally, although they are not very effective for migraine headaches. Triptans, such as sumatriptan (Imitrex), rizatriptan (Maxalt), eletriptan (Relpax) and other while not approved for pregnant women, may be safer and much more effective than either NSAIDs or narcotics. If a pregnant woman has frequent headaches, prevention with intravenous magnesium, biofeedback, and Botox injections should be tried before resorting to daily preventive drugs.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe